Abaloparatide is a medication used in the management and treatment of osteoporosis. It is in the parathyroid hormone-related protein analog class of medications. Most cases of osteoporosis occur in post-menopausal women. This activity highlights the indications, contraindications, activity, adverse effects, monitoring, and other key elements of abaloparatide therapy in the clinical setting as it relates to the essential information needed by an interprofessional care team managing patients with post-menopausal osteoporosis and its related conditions.

**Objectives:**
- Describe the mechanism of action of abaloparatide. 
- Identify the indications for abaloparatide therapy. 
- Identify the most common adverse effect associated with abaloparatide therapy.
- Explain the importance of monitoring patients on abaloparatide therapy, including serum calcium levels.